(Press-News.org) Wiley, one of the world’s largest publishers and a global leader in research and learning, today announced the 2024 release of the Mass Spectra of Designer Drugs.
This indispensable spectral database serves as a cornerstone for forensic laboratories worldwide, enabling swift identification of illicit substances. Sourced from both legal and underground literature, it provides access to the latest novel psychoactive substances (NPS) like variants of fentanyl, xylazine, various opioids, synthetic cannabinoids, and more.
This annually refreshed database provides access to 35,094 mass spectra representing 26,712 unique chemical entities, along with detailed information and chemical structures. This year’s update introduces over 850 new mass spectra and over 500 new, unique compounds in major categories of interest.
“With newly synthesized NPS drugs hitting the streets daily, it’s critical for forensic labs to have access to the most recent data to keep up. For labs using mass spec to identify drugs, this is an essential resource,” said Graeme Whitley, Director, Data Science Solutions at Wiley.
Mass Spectra of Designer Drugs is compatible with most major mass spectrometry data systems. It is now also available as a KnowItAll subscription for use with Wiley's KnowItAll spectral analysis software, with innovative tools to assist in the identification of novel compounds using structure/fragment relationships.
Learn more at Wiley Science Solutions:
https://sciencesolutions.wiley.com/solutions/technique/gc-ms/mass-spectra-of-designer-drugs/
END
Wiley releases Mass Spectra of Designer Drugs 2024 to accelerate forensics analysis of fentanyls, cannabinoids, and more
2024-04-12
ELSE PRESS RELEASES FROM THIS DATE:
Freestanding emergency departments are popular, but do they function as intended?
2024-04-12
By Ann Kellett, Texas A&M University School of Public Health
Freestanding emergency departments (EDs) — either satellite branches of hospitals or independently operated facilities — have popped up across the country. Texas has the most, with 338 freestanding EDs as of May 2023, and these facilities handle nearly one quarter of all emergency department visits in the state.
Now, a new study from the Texas A&M University School of Public Health is the first to compare the characteristics of visits to freestanding EDs with visits to traditional hospital-based ...
University of Cincinnati experts present at national neurology conference
2024-04-12
University of Cincinnati researchers will present abstracts at the American Academy of Neurology annual meeting 2024, April 13-18 in Denver, Colorado.
Two-component treatment leads to improvement for patients
Late-onset Pompe disease (LOPD) is a rare, inherited genetic disease caused by the accumulation of glycogen, the body’s stored form of glucose, in muscles and other organs. Left untreated, the muscle weakness it causes can lead to the loss of the ability to walk and breathing impairment.
A research team led by UC’s ...
Bonobos are more aggressive than previously thought
2024-04-12
Chimpanzees and bonobos are often thought to reflect two different sides of human nature—the conflict-ready chimpanzee versus the peaceful bonobo—but a new study publishing April 12 in the journal Current Biology shows that, within their own communities, male bonobos are more frequently aggressive than male chimpanzees. For both species, more aggressive males had more mating opportunities.
“Chimpanzees and bonobos use aggression in different ways for specific reasons,” says anthropologist and lead author Maud Mouginot of Boston University. “The idea is not to invalidate the ...
How seaweed became multicellular
2024-04-12
A deep dive into macroalgae genetics has uncovered the genetic underpinnings that enabled macroalgae, or “seaweed,” to evolve multicellularity. Three lineages of macroalgae developed multicellularity independently and during very different time periods by acquiring genes that enable cell adhesion, extracellular matrix formation, and cell differentiation, researchers report April 12 in the journal Molecular Plant. Surprisingly, many of these multicellular-enabling genes had viral origins. The study, which increased the total number of sequenced macroalgal genomes from 14 to 124, is the first to investigate ...
Melanomas resist drugs by ‘breaking’ genes
2024-04-12
Melanoma is the deadliest form of skin cancer. With global incidence rates rising, new, more effective treatments are necessary to alleviate the health burden of the disease. Important advances in recent years include doctors using genetic tests to look for specific mutations they can target for more personalised, effective treatment.
Around 1 in 2 melanoma patients will have mutations in the BRAF gene. This gene normally makes a protein which helps control cell growth, but mutations can cause the cells to grow and divide uncontrollably instead, happening in many different types of cancer including ...
Africa’s iconic flamingos threatened by rising lake levels, study shows
2024-04-12
It is one of the world’s most spectacular sights – huge flocks or “flamboyances” of flamingos around East Africa’s lakes – as seen in the film Out of Africa or David Attenborough’s A Perfect Planet.
But new research led by King’s College London has revealed how the lesser flamingo is at danger of being flushed out of its historic feeding grounds, with serious consequences for the future of the species.
For the first time satellite earth observation data has been used to study all the key flamingo feeding lakes in Ethiopia, Kenya and Tanzania over two decades and it identified how rising ...
Vaccination timeliness among US children ages 0-19 months
2024-04-12
About The Study: In this study of National Immunization Survey–Child data, improvements in vaccination timeliness were observed from the 2011 to the 2021 survey. However, widening disparities by socioeconomic indicators signal that increased efforts to facilitate timely vaccination among children in lower-income families are needed.
Authors: Sophia R. Newcomer, Ph.D., M.P.H., of the University of Montana, Missoula, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this ...
Changes in permanent contraception procedures among young adults following the Dobbs decision
2024-04-12
About The Study: Researchers observed an abrupt increase in permanent contraception procedures among adults ages 18 to 30 following Dobbs. The increase in procedures for female patients was double that for male patients. These patterns offer insights into the gendered dynamics of permanent contraceptive use and may reflect the disproportionate health, social, and economic consequences of compulsory pregnancy on women and people with the capacity to become pregnant.
Authors: Jacqueline E. Ellison, Ph.D., of the University of Pittsburgh School of Public Health, is the corresponding author.
To access the embargoed study: Visit our For The Media website ...
Semaglutide vs endoscopic sleeve gastroplasty for weight loss
2024-04-12
About The Study: The results of this study suggest that endoscopic sleeve gastroplasty is cost saving compared with semaglutide in the treatment of class II obesity. On price threshold analyses, a 3-fold decrease in the price of semaglutide is needed to achieve nondominance.
Authors: Christopher C. Thompson, M.D., M.Sc., of Brigham and Women’s Hospital in Boston, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2024.6221)
Editor’s Note: Please ...
First national study of Dobbs ruling’s effect on permanent contraception among young adults
2024-04-12
The first study to evaluate the effect of the Dobbs v. Jackson Women's Health Organization ruling on permanent contraception procedures among young adults nationwide was published today in a JAMA Health Forum research letter.
The study, authored by policy researchers from the University of Pittsburgh School of Public Health and Boston University, underscores how the 2022 U.S. Supreme Court ruling changed preferences for permanent contraception among people ages 18 to 30, who are more likely to have abortions and are also more likely to experience sterilization regret compared to people over 30.
The study is also the first to assess how the Dobbs ruling ...